Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
about
Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatasesGenomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasisFragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins.Leptin Signaling Mediates Obesity-associated CSC Enrichment and EMT in Preclinical TNBC Models.MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.
P2860
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
@en
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
@nl
type
label
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
@en
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
@nl
prefLabel
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
@en
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Investigation of molecular alterations of AKT-3 in triple-negative breast cancer.
@en
P2093
Aisling Pierce
Anthony O'Grady
Cecily Quinn
Dara Fitzgerald
Elaine W Kay
Etáin Daly
Gillian O'Hurley
Louise Flanagan
Michael J Duffy
Miriam A Lynn
P2860
P304
P356
10.1111/HIS.12313
P577
2013-12-12T00:00:00Z